Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIEOP-BFM ALL 2009 for pediatric acute lymphoblastic leukemia
NCT01117441Phase 3Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Jun 2010
- Primary completion
- Dec 2021
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of pegaspargase, daunorubicin in acute lymphoblastic leukemia (ALL), sponsored by Universitätsklinikum Schleswig-Holstein. Started Jun 2010; status: completed.
02
Drugs
pegaspargasedaunorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01117441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01117441.